Clinical Trial Update: Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT) [NA]

View source ↗

Summary

A completed clinical trial in individuals with High Altitude Pulmonary Hypertension assessing pulmonary arterial pressure at 3200 meters with and without supple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High Altitude Pulmonary Hypertension

Snippet

Sponsor: University of Zurich | Conditions: High Altitude Pulmonary Hypertension | NA | Status: COMPLETED